Search

Your search keyword '"Yoon, Dok-Hyun"' showing total 19 results
Start Over Author "Yoon, Dok-Hyun" Journal blood research
19 results on '"Yoon, Dok-Hyun"'

2. Multicenter retrospective analysis of patients with chronic lymphocytic leukemia in Korea

Author

Yi, Jun Ho, primary, Lee, Gyeong-Won, additional, Lee, Ji Hyun, additional, Yoo, Kwai Han, additional, Jung, Chul Won, additional, Kim, Dae Sik, additional, Lee, Jeong-Ok, additional, Eom, Hyeon Seok, additional, Byun, Ja Min, additional, Koh, Youngil, additional, Yoon, Sung Soo, additional, Kim, Jin Seok, additional, Kong, Jee Hyun, additional, Yhim, Ho-Young, additional, Yang, Deok-Hwan, additional, Yoon, Dok Hyun, additional, Lim, Do Hyoung, additional, Lee, Won-Sik, additional, and Shin, Ho-Jin, additional

Published
2021
Full Text
View/download PDF

4. Platelet to lymphocyte ratio (PLR) retains independent prognostic significance in advanced stage marginal zone lymphoma patients treated with rituximab, cyclophosphamide, vincristine, and prednisone combination chemotherapy (R-CVP): Consortium for Improving Survival of Lymphoma trial

Author

Seo, Jeongkuk, primary, Kim, Won Seog, additional, Kim, Jin Seok, additional, Kim, Seok Jin, additional, Lee, Jae Hoon, additional, Hong, Jun Shik, additional, Lee, Gyeong-Won, additional, Oh, Sung Yong, additional, Lee, Ji-Hyun, additional, Yoon, Dok Hyun, additional, Lee, Won-Sik, additional, Kim, Hyo Jung, additional, Kwak, Jae-Yong, additional, Kang, Hye Jin, additional, Jo, Jae-Cheol, additional, Park, Yong, additional, Lee, Ho Sup, additional, Kim, Hyo-Jin, additional, and Suh, Cheolwon, additional

Published
2017
Full Text
View/download PDF

8. Intraocular lymphoma in Korea: the Consortium for Improving Survival of Lymphoma (CISL) study

Author

Lee, Seul, primary, Kim, Moon Jin, additional, Kim, Jin Seok, additional, Oh, Sung Yong, additional, Kim, Seok Jin, additional, Kwon, Yoon Hyung, additional, Chung, In Young, additional, Kang, Jung Hun, additional, Yang, Deok-Hwan, additional, Kang, Hye Jin, additional, Yoon, Dok Hyun, additional, Kim, Won Seog, additional, Kim, Hyo-Jin, additional, and Suh, Cheolwon, additional

Published
2015
Full Text
View/download PDF

19. Bendamustine in heavily pre-treated multiple myeloma patients: Results of a retrospective analysis from the Korean Multiple Myeloma Working Party.

Author

Kim SJ, Bang SM, Choi YS, Jo DY, Kim JS, Lee H, Eom HS, Yoon DH, Suh C, Lee JJ, Hong J, Lee JH, Koh Y, Kim K, Yoon SS, and Min CK

Abstract

Background: Bendamustine may be a potential treatment option for patients with myeloma, but little is known about the utility of bendamustine as a salvage treatment, especially in Asian patients., Methods: We performed a multicenter retrospective study of patients with relapsed or refractory myeloma who received bendamustine and prednisone., Results: The records of 65 heavily pre-treated patients, who had undergone bortezomib and lenalidomide treatment (median number of previous treatments: 5), were analyzed. The median time from diagnosis to bendamustine treatment was 3.8 years, and the median patient age was 63 years (range, 38‒77 yr). The responses to the last treatment before bendamustine were refractory disease (N=52, 80%) or disease progression from partial response (N=13, 20%). Twenty-three patients responded to the treatment, with an overall response rate of 35% (23/65), and the median number of bendamustine treatment cycles was two (range, 1‒5 cycles). The median overall survival after bendamustine treatment was 5.5 months and the overall survival rate in responders to bendamustine was significantly better than that in non-responders ( P =0.036)., Conclusion: Bendamustine may be a potential salvage treatment to extend survival in a select group of heavily pre-treated patients with relapsed or refractory myeloma., Competing Interests: Authors' Disclosures of Potential Conflicts of Interest: No potential conflicts of interest relevant to this article were reported.

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results